Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 9.11506609 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 9.11506609 |
3 | cellular response to interleukin-15 (GO:0071350) | 7.07249607 |
4 | response to interleukin-15 (GO:0070672) | 6.56510416 |
5 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.28227801 |
6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.09648026 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.08588961 |
8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.61232725 |
9 | tolerance induction (GO:0002507) | 5.60250006 |
10 | neuronal action potential (GO:0019228) | 5.59498232 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.52286303 |
12 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.13234978 |
13 | negative T cell selection (GO:0043383) | 5.01712480 |
14 | negative thymic T cell selection (GO:0045060) | 5.00885879 |
15 | urinary tract smooth muscle contraction (GO:0014848) | 5.00155975 |
16 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.87847110 |
17 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.79328125 |
18 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.79328125 |
19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.79236267 |
20 | behavioral response to pain (GO:0048266) | 4.69208612 |
21 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.62457413 |
22 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.54017965 |
23 | regulation of platelet aggregation (GO:0090330) | 4.52831546 |
24 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.48971040 |
25 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.43756865 |
26 | negative regulation of T cell mediated immunity (GO:0002710) | 4.43488992 |
27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.40072866 |
28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.33890776 |
29 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.32349441 |
30 | neuron cell-cell adhesion (GO:0007158) | 4.23457268 |
31 | positive thymic T cell selection (GO:0045059) | 4.23321420 |
32 | interferon-gamma production (GO:0032609) | 4.19317397 |
33 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19202366 |
34 | response to muramyl dipeptide (GO:0032495) | 4.17435487 |
35 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.17033895 |
36 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.16044719 |
37 | regulation of memory T cell differentiation (GO:0043380) | 4.13787879 |
38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.11206368 |
39 | regulation of cell killing (GO:0031341) | 4.10265847 |
40 | cornea development in camera-type eye (GO:0061303) | 4.08105373 |
41 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.03950514 |
42 | peripheral nervous system neuron development (GO:0048935) | 4.03458762 |
43 | leukocyte aggregation (GO:0070486) | 4.02511048 |
44 | presynaptic membrane assembly (GO:0097105) | 4.02171678 |
45 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.01054719 |
46 | membrane depolarization during action potential (GO:0086010) | 4.00338437 |
47 | negative regulation of innate immune response (GO:0045824) | 3.98011533 |
48 | neutrophil activation involved in immune response (GO:0002283) | 3.82632582 |
49 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.82031642 |
50 | mast cell activation (GO:0045576) | 3.81311355 |
51 | neutrophil activation (GO:0042119) | 3.80558169 |
52 | positive regulation of cell killing (GO:0031343) | 3.80522560 |
53 | leukocyte degranulation (GO:0043299) | 3.76861713 |
54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.75841964 |
55 | negative regulation of dendrite development (GO:2000171) | 3.75392402 |
56 | activated T cell proliferation (GO:0050798) | 3.75343518 |
57 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.74168806 |
58 | positive T cell selection (GO:0043368) | 3.74035955 |
59 | natural killer cell activation (GO:0030101) | 3.67994798 |
60 | response to pain (GO:0048265) | 3.65695684 |
61 | thymic T cell selection (GO:0045061) | 3.65548735 |
62 | natural killer cell activation involved in immune response (GO:0002323) | 3.62429467 |
63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.61840887 |
64 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.61482689 |
65 | * adenosine metabolic process (GO:0046085) | 3.59721979 |
66 | T cell migration (GO:0072678) | 3.54845782 |
67 | protein localization to synapse (GO:0035418) | 3.54773661 |
68 | regulation of mast cell degranulation (GO:0043304) | 3.54652250 |
69 | positive regulation of T cell mediated immunity (GO:0002711) | 3.53771382 |
70 | regulation of germinal center formation (GO:0002634) | 3.53622718 |
71 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.53011672 |
72 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.50588177 |
73 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.50578367 |
74 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.50578367 |
75 | cellular extravasation (GO:0045123) | 3.49723134 |
76 | T cell selection (GO:0045058) | 3.47907579 |
77 | lymph node development (GO:0048535) | 3.47573447 |
78 | positive regulation of T cell cytokine production (GO:0002726) | 3.46529708 |
79 | mast cell degranulation (GO:0043303) | 3.46104473 |
80 | mast cell activation involved in immune response (GO:0002279) | 3.46104473 |
81 | regulation of T cell mediated immunity (GO:0002709) | 3.45116099 |
82 | regulation of regulatory T cell differentiation (GO:0045589) | 3.41620596 |
83 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.41489602 |
84 | presynaptic membrane organization (GO:0097090) | 3.40038946 |
85 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.38653989 |
86 | vocalization behavior (GO:0071625) | 3.36928171 |
87 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.30699436 |
88 | regulation of mast cell activation (GO:0033003) | 3.29420694 |
89 | granulocyte activation (GO:0036230) | 3.29029961 |
90 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.27731713 |
91 | detection of calcium ion (GO:0005513) | 3.26232873 |
92 | action potential (GO:0001508) | 3.21841709 |
93 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.20213409 |
94 | desmosome organization (GO:0002934) | 3.18797415 |
95 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.15374784 |
96 | postsynaptic membrane organization (GO:0001941) | 3.15141665 |
97 | cell migration in hindbrain (GO:0021535) | 3.13821279 |
98 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11877069 |
99 | neuromuscular synaptic transmission (GO:0007274) | 3.08541042 |
100 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.06502862 |
101 | negative regulation of adaptive immune response (GO:0002820) | 3.06374510 |
102 | glycosphingolipid biosynthetic process (GO:0006688) | 3.05214319 |
103 | megakaryocyte development (GO:0035855) | 3.03502761 |
104 | regulation of leukocyte mediated immunity (GO:0002703) | 3.02276904 |
105 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.01934724 |
106 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.01394761 |
107 | myeloid cell activation involved in immune response (GO:0002275) | 2.98414946 |
108 | regulation of sensory perception of pain (GO:0051930) | 2.97587252 |
109 | regulation of sensory perception (GO:0051931) | 2.97587252 |
110 | B cell receptor signaling pathway (GO:0050853) | 2.97230320 |
111 | dendritic cell chemotaxis (GO:0002407) | 2.97066249 |
112 | cellular defense response (GO:0006968) | 2.96991085 |
113 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.96351132 |
114 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95522436 |
115 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.94297075 |
116 | positive regulation of muscle hypertrophy (GO:0014742) | 2.93204310 |
117 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.93204310 |
118 | natural killer cell differentiation (GO:0001779) | 2.93190426 |
119 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.92153719 |
120 | positive regulation of mast cell activation (GO:0033005) | 2.91849609 |
121 | regulation of B cell differentiation (GO:0045577) | 2.91488279 |
122 | RNA destabilization (GO:0050779) | 2.90980930 |
123 | T cell proliferation (GO:0042098) | 2.90508803 |
124 | neuronal action potential propagation (GO:0019227) | 2.90474670 |
125 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.89002566 |
126 | positive regulation of macrophage differentiation (GO:0045651) | 2.88865125 |
127 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.88621665 |
128 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.88121682 |
129 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.88094126 |
130 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.87935543 |
131 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.86404952 |
132 | regulation of T cell tolerance induction (GO:0002664) | 2.84794012 |
133 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.84547039 |
134 | positive regulation of amino acid transport (GO:0051957) | 2.83942773 |
135 | positive regulation of action potential (GO:0045760) | 2.83405590 |
136 | T cell receptor signaling pathway (GO:0050852) | 2.83384510 |
137 | positive regulation of tolerance induction (GO:0002645) | 2.82997743 |
138 | regulation of T-helper 1 type immune response (GO:0002825) | 2.82045964 |
139 | dendritic cell migration (GO:0036336) | 2.80986750 |
140 | positive regulation of interleukin-17 production (GO:0032740) | 2.80525866 |
141 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.80321006 |
142 | modulation by symbiont of host defense response (GO:0052031) | 2.78286452 |
143 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.78286452 |
144 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.78286452 |
145 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.78286452 |
146 | modulation by symbiont of host immune response (GO:0052553) | 2.78286452 |
147 | positive regulation by symbiont of host defense response (GO:0052509) | 2.78286452 |
148 | regulation of collateral sprouting (GO:0048670) | 2.77909176 |
149 | hepatocyte apoptotic process (GO:0097284) | 2.77619375 |
150 | membrane depolarization (GO:0051899) | 2.77541537 |
151 | glutamate receptor signaling pathway (GO:0007215) | 2.74868889 |
152 | acrosome reaction (GO:0007340) | 2.73660530 |
153 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.72965641 |
154 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.72011706 |
155 | synaptic vesicle exocytosis (GO:0016079) | 2.69282539 |
156 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.69072234 |
157 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.65658630 |
158 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.65658630 |
159 | sensory perception of pain (GO:0019233) | 2.63469267 |
160 | membrane assembly (GO:0071709) | 2.63159838 |
161 | response to ATP (GO:0033198) | 2.61808015 |
162 | neurofilament cytoskeleton organization (GO:0060052) | 2.61127863 |
163 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.60335249 |
164 | keratinocyte development (GO:0003334) | 2.59184195 |
165 | sympathetic nervous system development (GO:0048485) | 2.57475632 |
166 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57358307 |
167 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.56107719 |
168 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.54564889 |
169 | aggressive behavior (GO:0002118) | 2.53112377 |
170 | regulation of action potential (GO:0098900) | 2.53092342 |
171 | keratinocyte proliferation (GO:0043616) | 2.52599098 |
172 | potassium ion export (GO:0071435) | 2.51681924 |
173 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.48971518 |
174 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.48546777 |
175 | opioid receptor signaling pathway (GO:0038003) | 2.47843956 |
176 | cellular potassium ion transport (GO:0071804) | 2.47338833 |
177 | potassium ion transmembrane transport (GO:0071805) | 2.47338833 |
178 | rhodopsin mediated signaling pathway (GO:0016056) | 2.46708814 |
179 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.45968773 |
180 | detection of temperature stimulus (GO:0016048) | 2.44620753 |
181 | regulation of synapse assembly (GO:0051963) | 2.44553131 |
182 | modulation by virus of host process (GO:0019054) | 2.43973593 |
183 | retinal ganglion cell axon guidance (GO:0031290) | 2.42477282 |
184 | transmission of nerve impulse (GO:0019226) | 2.41751473 |
185 | neuron-neuron synaptic transmission (GO:0007270) | 2.40114631 |
186 | synaptic transmission, glutamatergic (GO:0035249) | 2.40049670 |
187 | multicellular organismal response to stress (GO:0033555) | 2.39343688 |
188 | dopamine receptor signaling pathway (GO:0007212) | 2.39124075 |
189 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.38415797 |
190 | potassium ion transport (GO:0006813) | 2.38030646 |
191 | positive regulation of synapse assembly (GO:0051965) | 2.37973373 |
192 | limb bud formation (GO:0060174) | 2.35192888 |
193 | regulation of neurotransmitter secretion (GO:0046928) | 2.34905811 |
194 | serotonin receptor signaling pathway (GO:0007210) | 2.33883100 |
195 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.32586240 |
196 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.32166525 |
197 | negative regulation of platelet activation (GO:0010544) | 2.32049492 |
198 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.32015822 |
199 | negative regulation of protein localization to cell surface (GO:2000009) | 2.31996017 |
200 | regulation of membrane depolarization (GO:0003254) | 2.29867755 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.86473221 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.70806929 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.22764494 |
4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.37428264 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.05113511 |
6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.59187203 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.31942410 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28264747 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.16387692 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.06867537 |
11 | * MYB_26560356_Chip-Seq_TH2_Human | 2.98088571 |
12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.82994425 |
13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.80228430 |
14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.79742744 |
15 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.75451945 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.71854093 |
17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.68397998 |
18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.67588894 |
19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.58350802 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.56147154 |
21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53781841 |
22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52028366 |
23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47740400 |
24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47209864 |
25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.47135691 |
26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46740593 |
27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45820467 |
28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.45577757 |
29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44495933 |
30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.38603254 |
31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35288138 |
32 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33509644 |
33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.29922693 |
34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.29521696 |
35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.29403782 |
36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.27802821 |
37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.27802821 |
38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.26000198 |
39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.24777424 |
40 | MAF_26560356_Chip-Seq_TH1_Human | 2.21779052 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 2.17140030 |
42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12698072 |
43 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.09225430 |
44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.08186227 |
45 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06646038 |
46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05696792 |
47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03415500 |
48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.02773208 |
49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99957722 |
50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.99341781 |
51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.98913456 |
52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96967289 |
53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.96761051 |
54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.94558080 |
55 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92603994 |
56 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91532222 |
57 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.86253376 |
58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.85550426 |
59 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85128219 |
60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.83932981 |
61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82858745 |
62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82483046 |
63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80303762 |
64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79716411 |
65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.77273501 |
66 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76749120 |
67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75267358 |
68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72014295 |
69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.71035951 |
70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.69088052 |
71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68530010 |
72 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66568225 |
73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66310993 |
74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64095800 |
75 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64063661 |
76 | MAF_26560356_Chip-Seq_TH2_Human | 1.62700478 |
77 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.60619118 |
78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60344357 |
79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.59337206 |
80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.58497690 |
81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.53080121 |
82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.52864046 |
83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49798197 |
84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.49360811 |
85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48426819 |
86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.47160753 |
87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47160753 |
88 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46215098 |
89 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45736750 |
90 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.45510667 |
91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.42667537 |
92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42059778 |
93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42006532 |
94 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41844148 |
95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41311673 |
96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39275211 |
97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38765791 |
98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37291191 |
99 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37290422 |
100 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36891945 |
101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.35696147 |
102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35299789 |
103 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.35188181 |
104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.34992721 |
105 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.33659585 |
106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.33281868 |
107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32656090 |
108 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.31201405 |
109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30790411 |
110 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.30543701 |
111 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30321242 |
112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29434335 |
113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28517690 |
114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28364245 |
115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27987267 |
116 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27865037 |
117 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27146504 |
118 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25964438 |
119 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.25706739 |
120 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24787495 |
121 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24532027 |
122 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23571206 |
123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22765912 |
124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22250121 |
125 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22225672 |
126 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20344204 |
127 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20201996 |
128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19920144 |
129 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19623269 |
130 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18550202 |
131 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18471383 |
132 | KDM2B_26808549_Chip-Seq_REH_Human | 1.17481396 |
133 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17096711 |
134 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17068325 |
135 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16704402 |
136 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16638848 |
137 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.16295596 |
138 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16232802 |
139 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15735949 |
140 | JUN_21703547_ChIP-Seq_K562_Human | 1.15625067 |
141 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.15393203 |
142 | MYC_22102868_ChIP-Seq_BL_Human | 1.14120029 |
143 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13578975 |
144 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12768753 |
145 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11866639 |
146 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10954339 |
147 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.10762946 |
148 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10053960 |
149 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09887834 |
150 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.08590608 |
151 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08475607 |
152 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08369660 |
153 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07539573 |
154 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07374623 |
155 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07341907 |
156 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06839384 |
157 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06810654 |
158 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06577972 |
159 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06335624 |
160 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06160534 |
161 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06054388 |
162 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04369290 |
163 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.03334736 |
164 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02570725 |
165 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00177262 |
166 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00014278 |
167 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99560693 |
168 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99005313 |
169 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95753008 |
170 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95283549 |
171 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95273812 |
172 | GATA3_26560356_Chip-Seq_TH1_Human | 0.95164680 |
173 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95037715 |
174 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94563430 |
175 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93537061 |
176 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93468092 |
177 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92504185 |
178 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90725602 |
179 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90397419 |
180 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.86792557 |
181 | P300_27268052_Chip-Seq_Bcells_Human | 0.86629449 |
182 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85786857 |
183 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85631342 |
184 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83415456 |
185 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81360581 |
186 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80881020 |
187 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77844751 |
188 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76562344 |
189 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76516324 |
190 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75927528 |
191 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73622499 |
192 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73068487 |
193 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71095089 |
194 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.70692734 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001968_abnormal_touch/_nociception | 6.16924218 |
2 | MP0002736_abnormal_nociception_after | 5.91369393 |
3 | MP0002735_abnormal_chemical_nociception | 5.90170003 |
4 | MP0001986_abnormal_taste_sensitivity | 4.31633835 |
5 | MP0003436_decreased_susceptibility_to | 4.06200391 |
6 | MP0001835_abnormal_antigen_presentation | 3.68599171 |
7 | MP0003763_abnormal_thymus_physiology | 3.56812482 |
8 | MP0002734_abnormal_mechanical_nocicepti | 3.24791253 |
9 | MP0005000_abnormal_immune_tolerance | 3.21408401 |
10 | MP0006276_abnormal_autonomic_nervous | 3.09786460 |
11 | MP0000685_abnormal_immune_system | 3.09317118 |
12 | MP0002733_abnormal_thermal_nociception | 3.07767576 |
13 | MP0000465_gastrointestinal_hemorrhage | 3.05218749 |
14 | MP0001800_abnormal_humoral_immune | 3.04674101 |
15 | MP0004270_analgesia | 2.97387799 |
16 | MP0003880_abnormal_central_pattern | 2.81074639 |
17 | MP0001970_abnormal_pain_threshold | 2.77617010 |
18 | MP0002723_abnormal_immune_serum | 2.75783111 |
19 | MP0001188_hyperpigmentation | 2.75021115 |
20 | MP0009785_altered_susceptibility_to | 2.70685596 |
21 | MP0001819_abnormal_immune_cell | 2.59845222 |
22 | MP0002420_abnormal_adaptive_immunity | 2.58573290 |
23 | MP0005025_abnormal_response_to | 2.51590349 |
24 | MP0002452_abnormal_antigen_presenting | 2.50619875 |
25 | MP0002419_abnormal_innate_immunity | 2.50613263 |
26 | MP0005387_immune_system_phenotype | 2.43476950 |
27 | MP0001790_abnormal_immune_system | 2.43476950 |
28 | MP0006082_CNS_inflammation | 2.41745636 |
29 | MP0001533_abnormal_skeleton_physiology | 2.40129221 |
30 | MP0005464_abnormal_platelet_physiology | 2.30454272 |
31 | MP0002398_abnormal_bone_marrow | 2.16514258 |
32 | MP0005646_abnormal_pituitary_gland | 2.15738969 |
33 | MP0002272_abnormal_nervous_system | 2.07834398 |
34 | MP0008260_abnormal_autophagy | 2.07721060 |
35 | MP0004859_abnormal_synaptic_plasticity | 2.05692284 |
36 | MP0002148_abnormal_hypersensitivity_rea | 2.05248911 |
37 | MP0001984_abnormal_olfaction | 2.05124567 |
38 | MP0000716_abnormal_immune_system | 2.05033587 |
39 | MP0004858_abnormal_nervous_system | 2.01673511 |
40 | * MP0002405_respiratory_system_inflammati | 2.01657950 |
41 | MP0000703_abnormal_thymus_morphology | 1.99136266 |
42 | MP0004947_skin_inflammation | 1.97690702 |
43 | MP0002722_abnormal_immune_system | 1.97194910 |
44 | MP0002067_abnormal_sensory_capabilities | 1.96543480 |
45 | MP0003635_abnormal_synaptic_transmissio | 1.93771411 |
46 | MP0002184_abnormal_innervation | 1.92726563 |
47 | MP0000689_abnormal_spleen_morphology | 1.89724160 |
48 | MP0001851_eye_inflammation | 1.87016088 |
49 | MP0010155_abnormal_intestine_physiology | 1.86307378 |
50 | MP0005075_abnormal_melanosome_morpholog | 1.79846324 |
51 | MP0003787_abnormal_imprinting | 1.77950756 |
52 | MP0003866_abnormal_defecation | 1.77378899 |
53 | MP0003183_abnormal_peptide_metabolism | 1.75776882 |
54 | MP0000566_synostosis | 1.75077048 |
55 | MP0001486_abnormal_startle_reflex | 1.71122318 |
56 | MP0003828_pulmonary_edema | 1.70267640 |
57 | MP0009745_abnormal_behavioral_response | 1.68987971 |
58 | MP0003303_peritoneal_inflammation | 1.66347816 |
59 | MP0001845_abnormal_inflammatory_respons | 1.64656678 |
60 | MP0002933_joint_inflammation | 1.63597365 |
61 | MP0002277_abnormal_respiratory_mucosa | 1.62591497 |
62 | MP0002429_abnormal_blood_cell | 1.60112625 |
63 | MP0002572_abnormal_emotion/affect_behav | 1.59627465 |
64 | MP0005171_absent_coat_pigmentation | 1.57759571 |
65 | MP0002166_altered_tumor_susceptibility | 1.55889770 |
66 | MP0002638_abnormal_pupillary_reflex | 1.51727444 |
67 | MP0002064_seizures | 1.51388938 |
68 | MP0002063_abnormal_learning/memory/cond | 1.49027288 |
69 | MP0000516_abnormal_urinary_system | 1.48910195 |
70 | MP0005367_renal/urinary_system_phenotyp | 1.48910195 |
71 | MP0005423_abnormal_somatic_nervous | 1.44592247 |
72 | MP0009333_abnormal_splenocyte_physiolog | 1.43914236 |
73 | MP0009046_muscle_twitch | 1.37153039 |
74 | MP0003656_abnormal_erythrocyte_physiolo | 1.36840893 |
75 | MP0008789_abnormal_olfactory_epithelium | 1.36609052 |
76 | MP0002998_abnormal_bone_remodeling | 1.36019940 |
77 | MP0001501_abnormal_sleep_pattern | 1.35802892 |
78 | MP0003941_abnormal_skin_development | 1.33751496 |
79 | MP0006292_abnormal_olfactory_placode | 1.30648714 |
80 | MP0002102_abnormal_ear_morphology | 1.29967991 |
81 | MP0005310_abnormal_salivary_gland | 1.28210296 |
82 | MP0000778_abnormal_nervous_system | 1.27661176 |
83 | MP0009764_decreased_sensitivity_to | 1.27156009 |
84 | MP0002009_preneoplasia | 1.26581185 |
85 | MP0001440_abnormal_grooming_behavior | 1.25975914 |
86 | MP0005645_abnormal_hypothalamus_physiol | 1.25536092 |
87 | MP0004043_abnormal_pH_regulation | 1.24219703 |
88 | MP0002138_abnormal_hepatobiliary_system | 1.23932797 |
89 | MP0002751_abnormal_autonomic_nervous | 1.23168151 |
90 | MP0005394_taste/olfaction_phenotype | 1.20540148 |
91 | MP0005499_abnormal_olfactory_system | 1.20540148 |
92 | MP0002557_abnormal_social/conspecific_i | 1.19876512 |
93 | MP0009278_abnormal_bone_marrow | 1.17172040 |
94 | MP0003300_gastrointestinal_ulcer | 1.17132554 |
95 | MP0002876_abnormal_thyroid_physiology | 1.15296504 |
96 | MP0004142_abnormal_muscle_tone | 1.15153549 |
97 | MP0004381_abnormal_hair_follicle | 1.13703599 |
98 | MP0008469_abnormal_protein_level | 1.12569339 |
99 | MP0001905_abnormal_dopamine_level | 1.12473701 |
100 | MP0002006_tumorigenesis | 1.10682083 |
101 | MP0001346_abnormal_lacrimal_gland | 1.08239647 |
102 | MP0000858_altered_metastatic_potential | 1.06651134 |
103 | MP0005390_skeleton_phenotype | 1.06026329 |
104 | MP0004742_abnormal_vestibular_system | 1.05307091 |
105 | MP0010386_abnormal_urinary_bladder | 1.02674645 |
106 | MP0003136_yellow_coat_color | 1.02431750 |
107 | MP0004130_abnormal_muscle_cell | 1.02253132 |
108 | MP0000015_abnormal_ear_pigmentation | 1.01301522 |
109 | MP0010771_integument_phenotype | 1.00889507 |
110 | MP0001873_stomach_inflammation | 1.00038131 |
111 | MP0005379_endocrine/exocrine_gland_phen | 0.99771373 |
112 | MP0001270_distended_abdomen | 0.98158931 |
113 | MP0003195_calcinosis | 0.96886143 |
114 | MP0009250_abnormal_appendicular_skeleto | 0.96022138 |
115 | MP0003878_abnormal_ear_physiology | 0.95001729 |
116 | MP0005377_hearing/vestibular/ear_phenot | 0.95001729 |
117 | MP0000579_abnormal_nail_morphology | 0.93895443 |
118 | MP0003191_abnormal_cellular_cholesterol | 0.93619945 |
119 | MP0009763_increased_sensitivity_to | 0.93343460 |
120 | MP0000681_abnormal_thyroid_gland | 0.92668967 |
121 | MP0002882_abnormal_neuron_morphology | 0.92641264 |
122 | MP0005409_darkened_coat_color | 0.92546523 |
123 | MP0001529_abnormal_vocalization | 0.90198757 |
124 | MP0001853_heart_inflammation | 0.90007503 |
125 | MP0000538_abnormal_urinary_bladder | 0.89800618 |
126 | MP0002837_dystrophic_cardiac_calcinosis | 0.88799937 |
127 | MP0003315_abnormal_perineum_morphology | 0.88462167 |
128 | MP0000372_irregular_coat_pigmentation | 0.88165899 |
129 | MP0003638_abnormal_response/metabolism_ | 0.87111493 |
130 | MP0000569_abnormal_digit_pigmentation | 0.87048306 |
131 | MP0005083_abnormal_biliary_tract | 0.86327797 |
132 | MP0002254_reproductive_system_inflammat | 0.85614349 |
133 | MP0000955_abnormal_spinal_cord | 0.85550594 |
134 | MP0004147_increased_porphyrin_level | 0.85257512 |
135 | MP0000249_abnormal_blood_vessel | 0.85223344 |
136 | MP0003252_abnormal_bile_duct | 0.84837045 |
137 | MP0000026_abnormal_inner_ear | 0.84668567 |
138 | MP0002752_abnormal_somatic_nervous | 0.84372786 |
139 | MP0003879_abnormal_hair_cell | 0.82814308 |
140 | MP0004811_abnormal_neuron_physiology | 0.81816319 |
141 | MP0002163_abnormal_gland_morphology | 0.80837402 |
142 | MP0000427_abnormal_hair_cycle | 0.80202208 |
143 | MP0001963_abnormal_hearing_physiology | 0.78558749 |
144 | MP0001765_abnormal_ion_homeostasis | 0.77500364 |
145 | MP0003724_increased_susceptibility_to | 0.73296139 |
146 | MP0003172_abnormal_lysosome_physiology | 0.72208933 |
147 | MP0002066_abnormal_motor_capabilities/c | 0.69389021 |
148 | MP0005397_hematopoietic_system_phenotyp | 0.69292571 |
149 | MP0001545_abnormal_hematopoietic_system | 0.69292571 |
150 | MP0009765_abnormal_xenobiotic_induced | 0.69031665 |
151 | MP0003795_abnormal_bone_structure | 0.66803027 |
152 | MP0001664_abnormal_digestion | 0.65736039 |
153 | MP0003938_abnormal_ear_development | 0.65516295 |
154 | MP0008872_abnormal_physiological_respon | 0.64913570 |
155 | MP0002653_abnormal_ependyma_morphology | 0.64839823 |
156 | MP0001663_abnormal_digestive_system | 0.64555834 |
157 | MP0002396_abnormal_hematopoietic_system | 0.64500166 |
158 | MP0008877_abnormal_DNA_methylation | 0.64402990 |
159 | MP0001502_abnormal_circadian_rhythm | 0.62733949 |
160 | MP0004885_abnormal_endolymph | 0.62149906 |
161 | MP0008569_lethality_at_weaning | 0.61877036 |
162 | MP0002095_abnormal_skin_pigmentation | 0.60152943 |
163 | MP0005167_abnormal_blood-brain_barrier | 0.60050794 |
164 | MP0002928_abnormal_bile_duct | 0.58886904 |
165 | MP0004484_altered_response_of | 0.58217685 |
166 | MP0001485_abnormal_pinna_reflex | 0.57904599 |
167 | MP0002233_abnormal_nose_morphology | 0.57622972 |
168 | MP0004883_abnormal_blood_vessel | 0.56581277 |
169 | MP0002019_abnormal_tumor_incidence | 0.56124073 |
170 | MP0003448_altered_tumor_morphology | 0.55778762 |
171 | MP0003690_abnormal_glial_cell | 0.55365160 |
172 | MP0008874_decreased_physiological_sensi | 0.55043964 |
173 | MP0000631_abnormal_neuroendocrine_gland | 0.54702515 |
174 | MP0005084_abnormal_gallbladder_morpholo | 0.54207612 |
175 | MP0002132_abnormal_respiratory_system | 0.53603329 |
176 | MP0000383_abnormal_hair_follicle | 0.52532142 |
177 | MP0005671_abnormal_response_to | 0.51874505 |
178 | MP0000537_abnormal_urethra_morphology | 0.51537103 |
179 | MP0009379_abnormal_foot_pigmentation | 0.50929739 |
180 | MP0005551_abnormal_eye_electrophysiolog | 0.50919469 |
181 | MP0003011_delayed_dark_adaptation | 0.50885182 |
182 | MP0006054_spinal_hemorrhage | 0.50220192 |
183 | MP0008873_increased_physiological_sensi | 0.50140355 |
184 | MP0003634_abnormal_glial_cell | 0.49875907 |
185 | MP0000049_abnormal_middle_ear | 0.49046733 |
186 | MP0005174_abnormal_tail_pigmentation | 0.48946771 |
187 | MP0004924_abnormal_behavior | 0.48077636 |
188 | MP0005386_behavior/neurological_phenoty | 0.48077636 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 5.65591721 |
2 | Abnormality of T cell number (HP:0011839) | 5.28656466 |
3 | Optic neuritis (HP:0100653) | 5.20440731 |
4 | Retrobulbar optic neuritis (HP:0100654) | 5.20440731 |
5 | Myositis (HP:0100614) | 5.13739136 |
6 | Orchitis (HP:0100796) | 4.93663647 |
7 | Eczematoid dermatitis (HP:0000976) | 4.86281925 |
8 | Severe combined immunodeficiency (HP:0004430) | 4.74522410 |
9 | Ulnar claw (HP:0001178) | 4.70237413 |
10 | Gastrointestinal infarctions (HP:0005244) | 4.69408592 |
11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.66515712 |
12 | Febrile seizures (HP:0002373) | 4.56770415 |
13 | Abnormal hair whorl (HP:0010721) | 4.54924927 |
14 | Hypothermia (HP:0002045) | 4.42740171 |
15 | Focal motor seizures (HP:0011153) | 4.29307127 |
16 | Stomatitis (HP:0010280) | 4.26397547 |
17 | IgG deficiency (HP:0004315) | 4.24688167 |
18 | Abnormality of T cells (HP:0002843) | 4.19321738 |
19 | Keratoconjunctivitis (HP:0001096) | 3.93985128 |
20 | Recurrent fungal infections (HP:0002841) | 3.85549717 |
21 | Abnormality of eosinophils (HP:0001879) | 3.81204032 |
22 | Keratoconjunctivitis sicca (HP:0001097) | 3.72646822 |
23 | Combined immunodeficiency (HP:0005387) | 3.64847973 |
24 | Encephalitis (HP:0002383) | 3.64059860 |
25 | Recurrent bronchitis (HP:0002837) | 3.57759957 |
26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.53579452 |
27 | Panhypogammaglobulinemia (HP:0003139) | 3.51026758 |
28 | Vasculitis (HP:0002633) | 3.47732587 |
29 | Pustule (HP:0200039) | 3.46415018 |
30 | Atonic seizures (HP:0010819) | 3.46180548 |
31 | Parakeratosis (HP:0001036) | 3.42107742 |
32 | Joint swelling (HP:0001386) | 3.39227543 |
33 | Pulmonary infiltrates (HP:0002113) | 3.38156166 |
34 | Arterial thrombosis (HP:0004420) | 3.37586001 |
35 | Leukocytosis (HP:0001974) | 3.36944911 |
36 | Recurrent bacterial skin infections (HP:0005406) | 3.36274537 |
37 | Aplasia cutis congenita (HP:0001057) | 3.35459418 |
38 | Upper limb muscle weakness (HP:0003484) | 3.33990478 |
39 | Recurrent abscess formation (HP:0002722) | 3.31107572 |
40 | Meningitis (HP:0001287) | 3.26503060 |
41 | Myokymia (HP:0002411) | 3.24352565 |
42 | Chin dimple (HP:0010751) | 3.21711020 |
43 | Mediastinal lymphadenopathy (HP:0100721) | 3.17905225 |
44 | Prolonged bleeding time (HP:0003010) | 3.16973095 |
45 | Hemoptysis (HP:0002105) | 3.14624507 |
46 | Submucous cleft hard palate (HP:0000176) | 3.13210226 |
47 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.12817142 |
48 | Recurrent cutaneous fungal infections (HP:0011370) | 3.12817142 |
49 | Focal seizures (HP:0007359) | 3.11633265 |
50 | Granulocytopenia (HP:0001913) | 3.07917146 |
51 | Epileptic encephalopathy (HP:0200134) | 3.07907137 |
52 | Anorexia (HP:0002039) | 3.04913144 |
53 | Chest pain (HP:0100749) | 3.03588768 |
54 | Abnormality of T cell physiology (HP:0011840) | 2.98797309 |
55 | Thyroiditis (HP:0100646) | 2.97833401 |
56 | Abnormality of macrophages (HP:0004311) | 2.97633351 |
57 | Lip pit (HP:0100267) | 2.95333915 |
58 | Eosinophilia (HP:0001880) | 2.94470241 |
59 | Epistaxis (HP:0000421) | 2.93839234 |
60 | Hyperventilation (HP:0002883) | 2.88363885 |
61 | Dysautonomia (HP:0002459) | 2.87759322 |
62 | Septo-optic dysplasia (HP:0100842) | 2.83962776 |
63 | Stomach cancer (HP:0012126) | 2.83327709 |
64 | Spontaneous hematomas (HP:0007420) | 2.83164869 |
65 | Pulmonary embolism (HP:0002204) | 2.82149441 |
66 | Abnormality of the prostate (HP:0008775) | 2.81125468 |
67 | Absent/shortened dynein arms (HP:0200106) | 2.80953865 |
68 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.80953865 |
69 | Alveolar cell carcinoma (HP:0006519) | 2.79361946 |
70 | Retinal dysplasia (HP:0007973) | 2.78029331 |
71 | Increased density of long bones (HP:0006392) | 2.68898780 |
72 | Obstructive lung disease (HP:0006536) | 2.67511349 |
73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67511349 |
74 | Nasolacrimal duct obstruction (HP:0000579) | 2.65074950 |
75 | White forelock (HP:0002211) | 2.63642799 |
76 | Abnormality of the lacrimal duct (HP:0011481) | 2.63642250 |
77 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.62596087 |
78 | Gingival bleeding (HP:0000225) | 2.62567005 |
79 | Petechiae (HP:0000967) | 2.61448893 |
80 | Bradycardia (HP:0001662) | 2.60317041 |
81 | Gangrene (HP:0100758) | 2.60174433 |
82 | Vertigo (HP:0002321) | 2.59053521 |
83 | Abnormality of the nasolacrimal system (HP:0000614) | 2.58997389 |
84 | Steppage gait (HP:0003376) | 2.58363738 |
85 | Abnormality of B cell number (HP:0010975) | 2.56894780 |
86 | Recurrent skin infections (HP:0001581) | 2.56719203 |
87 | Progressive cerebellar ataxia (HP:0002073) | 2.52889450 |
88 | IgM deficiency (HP:0002850) | 2.51305696 |
89 | Glomerulopathy (HP:0100820) | 2.51051546 |
90 | Hypomagnesemia (HP:0002917) | 2.51029507 |
91 | Patchy hypopigmentation of hair (HP:0011365) | 2.50293088 |
92 | Abnormality of the pleura (HP:0002103) | 2.49491467 |
93 | Medial flaring of the eyebrow (HP:0010747) | 2.46874349 |
94 | Persistence of primary teeth (HP:0006335) | 2.45162063 |
95 | Nephrogenic diabetes insipidus (HP:0009806) | 2.44459003 |
96 | Chronic hepatic failure (HP:0100626) | 2.44065637 |
97 | Lymphopenia (HP:0001888) | 2.39655471 |
98 | Genital tract atresia (HP:0001827) | 2.37735989 |
99 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.34299866 |
100 | Diplopia (HP:0000651) | 2.33703999 |
101 | Abnormality of binocular vision (HP:0011514) | 2.33703999 |
102 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31994340 |
103 | B lymphocytopenia (HP:0010976) | 2.30759385 |
104 | Recurrent viral infections (HP:0004429) | 2.30754960 |
105 | Vaginal atresia (HP:0000148) | 2.30434858 |
106 | Hypoplasia of the thymus (HP:0000778) | 2.28972890 |
107 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.28881688 |
108 | Polyneuropathy (HP:0001271) | 2.26887702 |
109 | Prostate neoplasm (HP:0100787) | 2.26586679 |
110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25058472 |
111 | Gait imbalance (HP:0002141) | 2.22765723 |
112 | Anhidrosis (HP:0000970) | 2.22491347 |
113 | Hemiplegia (HP:0002301) | 2.20871614 |
114 | Abnormality of secondary sexual hair (HP:0009888) | 2.19930706 |
115 | Abnormality of the axillary hair (HP:0100134) | 2.19930706 |
116 | Abnormality of pain sensation (HP:0010832) | 2.19558606 |
117 | Impaired pain sensation (HP:0007328) | 2.19558606 |
118 | Cutaneous finger syndactyly (HP:0010554) | 2.19501365 |
119 | Abnormality of the parathyroid morphology (HP:0011766) | 2.18488494 |
120 | Absent septum pellucidum (HP:0001331) | 2.17942756 |
121 | Renal cortical cysts (HP:0000803) | 2.17581694 |
122 | Abnormality of the right ventricle (HP:0001707) | 2.17055391 |
123 | Gastrointestinal stroma tumor (HP:0100723) | 2.16648391 |
124 | Failure to thrive in infancy (HP:0001531) | 2.15227592 |
125 | Dysostosis multiplex (HP:0000943) | 2.15161388 |
126 | Chronic otitis media (HP:0000389) | 2.14750795 |
127 | Optic nerve hypoplasia (HP:0000609) | 2.13980643 |
128 | Insidious onset (HP:0003587) | 2.13677188 |
129 | Termporal pattern (HP:0011008) | 2.13677188 |
130 | Inflammation of the large intestine (HP:0002037) | 2.13259014 |
131 | Keratitis (HP:0000491) | 2.13031702 |
132 | Congenital primary aphakia (HP:0007707) | 2.12448365 |
133 | Papilloma (HP:0012740) | 2.11619510 |
134 | Verrucae (HP:0200043) | 2.11619510 |
135 | True hermaphroditism (HP:0010459) | 2.11201075 |
136 | Bronchitis (HP:0012387) | 2.09818557 |
137 | Increased IgM level (HP:0003496) | 2.08844474 |
138 | Hypochromic anemia (HP:0001931) | 2.08469224 |
139 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.08340968 |
140 | Urticaria (HP:0001025) | 2.08146050 |
141 | Morphological abnormality of the middle ear (HP:0008609) | 2.07602914 |
142 | Abnormality of incisor morphology (HP:0011063) | 2.05723730 |
143 | Premature loss of primary teeth (HP:0006323) | 2.04437144 |
144 | Autoimmune hemolytic anemia (HP:0001890) | 2.04217548 |
145 | Abnormality of the pericardium (HP:0001697) | 2.03648340 |
146 | Osteomalacia (HP:0002749) | 2.03275610 |
147 | Xerostomia (HP:0000217) | 2.03061595 |
148 | Pancreatic fibrosis (HP:0100732) | 2.01781849 |
149 | Amaurosis fugax (HP:0100576) | 2.01766665 |
150 | Clumsiness (HP:0002312) | 2.01136921 |
151 | Increased corneal curvature (HP:0100692) | 2.01108864 |
152 | Keratoconus (HP:0000563) | 2.01108864 |
153 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.99915886 |
154 | Arthralgia (HP:0002829) | 1.99795201 |
155 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96985711 |
156 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96985711 |
157 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96985711 |
158 | Fetal akinesia sequence (HP:0001989) | 1.96822696 |
159 | Exotropia (HP:0000577) | 1.96572730 |
160 | Gastrointestinal inflammation (HP:0004386) | 1.96305757 |
161 | Abnormal ciliary motility (HP:0012262) | 1.95995743 |
162 | Abnormality of the septum pellucidum (HP:0007375) | 1.95302875 |
163 | Abnormality of magnesium homeostasis (HP:0004921) | 1.93855258 |
164 | Absence seizures (HP:0002121) | 1.93762841 |
165 | Preaxial hand polydactyly (HP:0001177) | 1.92669658 |
166 | Hypoproteinemia (HP:0003075) | 1.92025802 |
167 | Abnormality of the nasal septum (HP:0000419) | 1.91946109 |
168 | Autoimmune thrombocytopenia (HP:0001973) | 1.91538249 |
169 | Polyphagia (HP:0002591) | 1.90258389 |
170 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.89492330 |
171 | Conical tooth (HP:0000698) | 1.89324250 |
172 | Dialeptic seizures (HP:0011146) | 1.89139444 |
173 | Tubulointerstitial nephritis (HP:0001970) | 1.89054718 |
174 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.88394167 |
175 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.88394167 |
176 | Cupped ear (HP:0000378) | 1.86062651 |
177 | Generalized tonic-clonic seizures (HP:0002069) | 1.85011490 |
178 | Short tibia (HP:0005736) | 1.84977884 |
179 | Nasal speech (HP:0001611) | 1.84037042 |
180 | Abnormality of the corticospinal tract (HP:0002492) | 1.81746869 |
181 | Anosmia (HP:0000458) | 1.81744483 |
182 | Aqueductal stenosis (HP:0002410) | 1.81346845 |
183 | Absent speech (HP:0001344) | 1.81059210 |
184 | Congenital malformation of the right heart (HP:0011723) | 1.79776268 |
185 | Double outlet right ventricle (HP:0001719) | 1.79776268 |
186 | Action tremor (HP:0002345) | 1.77725229 |
187 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77186634 |
188 | Cutaneous syndactyly (HP:0012725) | 1.76453654 |
189 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.74855834 |
190 | Decreased central vision (HP:0007663) | 1.74040525 |
191 | Curly hair (HP:0002212) | 1.70664566 |
192 | Popliteal pterygium (HP:0009756) | 1.70236400 |
193 | Hip dysplasia (HP:0001385) | 1.70049418 |
194 | Abnormality of midbrain morphology (HP:0002418) | 1.69758536 |
195 | Molar tooth sign on MRI (HP:0002419) | 1.69758536 |
196 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.69438100 |
197 | Protruding tongue (HP:0010808) | 1.69371198 |
198 | Esotropia (HP:0000565) | 1.69327262 |
199 | Poor coordination (HP:0002370) | 1.65996278 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 4.93532295 |
2 | SIK3 | 4.74319509 |
3 | GRK6 | 4.36394747 |
4 | MAP4K1 | 3.52548866 |
5 | BMPR1B | 3.14139090 |
6 | MAP3K12 | 3.01365704 |
7 | RIPK4 | 2.81856337 |
8 | IKBKE | 2.70202323 |
9 | NTRK3 | 2.69849965 |
10 | MAP2K2 | 2.54334794 |
11 | JAK1 | 2.49414777 |
12 | IKBKB | 2.10157635 |
13 | TBK1 | 2.08432034 |
14 | GRK5 | 2.07120176 |
15 | CSK | 1.99952683 |
16 | ZAP70 | 1.95013992 |
17 | MUSK | 1.93492178 |
18 | TNIK | 1.91777816 |
19 | SIK2 | 1.80756170 |
20 | MAPK13 | 1.78239179 |
21 | BTK | 1.75288602 |
22 | MARK3 | 1.75215702 |
23 | BLK | 1.73325340 |
24 | MAP4K2 | 1.66726144 |
25 | CDK8 | 1.56471971 |
26 | SYK | 1.54781771 |
27 | BMPR2 | 1.54423815 |
28 | YES1 | 1.51799006 |
29 | MAP2K7 | 1.51764361 |
30 | KIT | 1.51452852 |
31 | AKT3 | 1.51363303 |
32 | LCK | 1.50733559 |
33 | TLK1 | 1.48973962 |
34 | EPHB2 | 1.48830668 |
35 | TXK | 1.48369951 |
36 | HCK | 1.46047823 |
37 | STK16 | 1.45027400 |
38 | ARAF | 1.42694240 |
39 | SGK2 | 1.41785182 |
40 | BCR | 1.41699735 |
41 | PRPF4B | 1.40505811 |
42 | PLK2 | 1.39569070 |
43 | ITK | 1.37226321 |
44 | TESK2 | 1.34097317 |
45 | TYK2 | 1.34018001 |
46 | TNK2 | 1.30954286 |
47 | LYN | 1.30745865 |
48 | IRAK1 | 1.26800625 |
49 | MAP3K14 | 1.26468855 |
50 | EPHA4 | 1.25905610 |
51 | ADRBK2 | 1.19947830 |
52 | SGK494 | 1.18125556 |
53 | SGK223 | 1.18125556 |
54 | MINK1 | 1.17816324 |
55 | PIM1 | 1.09067970 |
56 | ERBB3 | 1.06786181 |
57 | NTRK2 | 1.06529508 |
58 | PRKCE | 1.01432587 |
59 | PIM2 | 0.98243599 |
60 | NTRK1 | 0.97512002 |
61 | NME1 | 0.95940380 |
62 | CDK4 | 0.95490841 |
63 | INSRR | 0.94676138 |
64 | LMTK2 | 0.92466823 |
65 | MKNK2 | 0.90396467 |
66 | EPHB1 | 0.89886028 |
67 | CSF1R | 0.87546961 |
68 | BRAF | 0.84725664 |
69 | IRAK4 | 0.84153786 |
70 | STK24 | 0.83832649 |
71 | MAP3K13 | 0.79362322 |
72 | EPHA3 | 0.79017235 |
73 | TRPM7 | 0.78037008 |
74 | LIMK1 | 0.77093211 |
75 | MST4 | 0.76629538 |
76 | MAPK7 | 0.75056542 |
77 | CAMKK2 | 0.72330172 |
78 | GRK7 | 0.71753542 |
79 | PDK1 | 0.71490584 |
80 | TAOK1 | 0.71291927 |
81 | STK39 | 0.70884700 |
82 | MAP2K4 | 0.70755945 |
83 | MAP2K3 | 0.70454898 |
84 | FGFR2 | 0.69321989 |
85 | IRAK2 | 0.68693324 |
86 | MARK1 | 0.67569045 |
87 | ADRBK1 | 0.67290281 |
88 | FES | 0.67253031 |
89 | CHUK | 0.67052888 |
90 | ERN1 | 0.66629494 |
91 | CAMK2A | 0.66000839 |
92 | JAK2 | 0.65806054 |
93 | KDR | 0.65212934 |
94 | NEK6 | 0.64769273 |
95 | CDK5 | 0.64059586 |
96 | STK10 | 0.64031780 |
97 | PAK6 | 0.63454615 |
98 | PRKCG | 0.62076269 |
99 | MARK2 | 0.61789933 |
100 | FYN | 0.60047045 |
101 | PRKCQ | 0.58703921 |
102 | WNK4 | 0.57437592 |
103 | DAPK2 | 0.55306382 |
104 | NUAK1 | 0.54154054 |
105 | FRK | 0.53038463 |
106 | KSR2 | 0.52895002 |
107 | MAP3K2 | 0.52472642 |
108 | PIK3CG | 0.52170277 |
109 | STK38 | 0.51914524 |
110 | CDK3 | 0.51832844 |
111 | RPS6KA2 | 0.51785467 |
112 | PKN1 | 0.51193420 |
113 | SGK3 | 0.50730278 |
114 | RPS6KA6 | 0.49946443 |
115 | RAF1 | 0.49686751 |
116 | MAPK11 | 0.48802193 |
117 | CDK6 | 0.48160413 |
118 | FGR | 0.47966315 |
119 | GRK1 | 0.47770799 |
120 | RPS6KL1 | 0.47006278 |
121 | RPS6KC1 | 0.47006278 |
122 | MAP3K7 | 0.46345946 |
123 | DYRK2 | 0.45307072 |
124 | FER | 0.44945717 |
125 | PRKD2 | 0.44671638 |
126 | MST1R | 0.44230860 |
127 | EIF2AK2 | 0.42971091 |
128 | TEC | 0.42551639 |
129 | IGF1R | 0.42045609 |
130 | INSR | 0.42001072 |
131 | JAK3 | 0.41666985 |
132 | PRKACA | 0.41611256 |
133 | MAPKAPK2 | 0.41414497 |
134 | ZAK | 0.41137399 |
135 | PTK2B | 0.41047559 |
136 | ACVR1B | 0.39492117 |
137 | PIK3CA | 0.38811396 |
138 | MAP2K6 | 0.38601417 |
139 | TGFBR2 | 0.38199573 |
140 | MAP3K9 | 0.36935589 |
141 | ABL1 | 0.36656507 |
142 | MAPK12 | 0.36122242 |
143 | UHMK1 | 0.36035032 |
144 | MAP3K4 | 0.35919726 |
145 | SGK1 | 0.34976753 |
146 | RET | 0.34467938 |
147 | MAPK4 | 0.34217571 |
148 | MAPKAPK3 | 0.33873857 |
149 | MAPK3 | 0.33567499 |
150 | MATK | 0.32688672 |
151 | RPS6KA1 | 0.32176414 |
152 | CAMK2G | 0.31667182 |
153 | MAP2K1 | 0.31485654 |
154 | TAOK3 | 0.31339891 |
155 | OXSR1 | 0.31085423 |
156 | PRKCD | 0.30396939 |
157 | PRKCH | 0.30135956 |
158 | DYRK1A | 0.29974028 |
159 | ROCK1 | 0.29081346 |
160 | CAMKK1 | 0.27336140 |
161 | MAP3K3 | 0.27057412 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.77010343 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.80187024 |
3 | Taste transduction_Homo sapiens_hsa04742 | 2.61191338 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.49900822 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.42363914 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39700627 |
7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.38504151 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.38241360 |
9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.18610024 |
10 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.12604384 |
11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.06004646 |
12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.05957858 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 2.03166670 |
14 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.99741803 |
15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.99351561 |
16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.98055035 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94401099 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93380796 |
19 | Measles_Homo sapiens_hsa05162 | 1.91078916 |
20 | Malaria_Homo sapiens_hsa05144 | 1.90517638 |
21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.84723575 |
22 | Circadian entrainment_Homo sapiens_hsa04713 | 1.78557680 |
23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.73290295 |
24 | Insulin secretion_Homo sapiens_hsa04911 | 1.68493082 |
25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.64403901 |
26 | Phototransduction_Homo sapiens_hsa04744 | 1.62763095 |
27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.57487782 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.55904000 |
29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.54620815 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52973175 |
31 | Allograft rejection_Homo sapiens_hsa05330 | 1.52498176 |
32 | Salivary secretion_Homo sapiens_hsa04970 | 1.50992469 |
33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.50402851 |
34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46797802 |
35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.44588065 |
36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44076130 |
37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43949159 |
38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.43162561 |
39 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.42891018 |
40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.42234672 |
41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40853215 |
42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38575435 |
43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37141956 |
44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36276553 |
45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35958254 |
46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35501365 |
47 | Long-term potentiation_Homo sapiens_hsa04720 | 1.33516310 |
48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.32554728 |
49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30669217 |
50 | Tuberculosis_Homo sapiens_hsa05152 | 1.28190524 |
51 | Asthma_Homo sapiens_hsa05310 | 1.27989422 |
52 | Melanoma_Homo sapiens_hsa05218 | 1.26554680 |
53 | Platelet activation_Homo sapiens_hsa04611 | 1.25175619 |
54 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25049505 |
55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.24431247 |
56 | Axon guidance_Homo sapiens_hsa04360 | 1.22726254 |
57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21620157 |
58 | Long-term depression_Homo sapiens_hsa04730 | 1.20755319 |
59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20615804 |
60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.19474835 |
61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17138186 |
62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16616057 |
63 | Legionellosis_Homo sapiens_hsa05134 | 1.15083995 |
64 | Apoptosis_Homo sapiens_hsa04210 | 1.13780578 |
65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13155003 |
66 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12802159 |
67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05211534 |
68 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.03553181 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03424578 |
70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.01811788 |
71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00653398 |
72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99000563 |
73 | Mineral absorption_Homo sapiens_hsa04978 | 0.95729202 |
74 | Influenza A_Homo sapiens_hsa05164 | 0.95072837 |
75 | Phagosome_Homo sapiens_hsa04145 | 0.91508651 |
76 | Hepatitis B_Homo sapiens_hsa05161 | 0.90790010 |
77 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90658915 |
78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90484272 |
79 | Shigellosis_Homo sapiens_hsa05131 | 0.90228091 |
80 | Renin secretion_Homo sapiens_hsa04924 | 0.89863777 |
81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88997505 |
82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.87701763 |
83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86120043 |
84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85216550 |
85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84868518 |
86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84476399 |
87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83845880 |
88 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.83725857 |
89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82137512 |
90 | Hepatitis C_Homo sapiens_hsa05160 | 0.80625143 |
91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80033353 |
92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79650340 |
93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78811504 |
94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77906930 |
95 | Melanogenesis_Homo sapiens_hsa04916 | 0.75590192 |
96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.75267167 |
97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75162442 |
98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75159538 |
99 | Pertussis_Homo sapiens_hsa05133 | 0.71603460 |
100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69902967 |
101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69650532 |
102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69584164 |
103 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68936787 |
104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67387338 |
105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67131451 |
106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66503032 |
107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66473455 |
108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65682906 |
109 | Glioma_Homo sapiens_hsa05214 | 0.64955313 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.63981570 |
111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63668273 |
112 | Salmonella infection_Homo sapiens_hsa05132 | 0.63653646 |
113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62548466 |
114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60757780 |
115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60437097 |
116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57803036 |
117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57146092 |
118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57100819 |
119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56826084 |
120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55555478 |
121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55413685 |
122 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55223834 |
123 | Insulin resistance_Homo sapiens_hsa04931 | 0.55213367 |
124 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54544960 |
125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54429777 |
126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54150325 |
127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53594557 |
128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52623065 |
129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52276278 |
130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52163621 |
131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49563101 |
132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48169490 |
133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48026087 |
134 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47971592 |
135 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47544084 |
136 | Lysosome_Homo sapiens_hsa04142 | 0.47369315 |
137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46125229 |
138 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45920614 |
139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42823434 |
140 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42634676 |
141 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42444319 |
142 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42321413 |
143 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41835568 |
144 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41343253 |
145 | Gap junction_Homo sapiens_hsa04540 | 0.41047356 |
146 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.40245158 |
147 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39515583 |
148 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38705284 |
149 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38205479 |
150 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38192056 |
151 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37924224 |
152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37789814 |
153 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37274852 |
154 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36078369 |
155 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35958908 |
156 | ABC transporters_Homo sapiens_hsa02010 | 0.32954696 |
157 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30887739 |
158 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29786025 |
159 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26818296 |
160 | Prostate cancer_Homo sapiens_hsa05215 | 0.25002408 |